| In the present case report, topiroxostat treatment in hyperuricemic patients with renal arteriolopathy reduced renal damage and increased flow-mediated dilation value. |
| Further studies are needed to assess the protective effects of topiroxostat treatment on renal and endothelial function in hyperuricemic patients. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.